$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Pharmacokinetics and diuretic effect of furosemide after single intravenous, oral tablet, and newly developed oral disintegrating film administration in healthy beagle dogs 원문보기

BMC veterinary research, v.17, 2021년, pp.295 -   

Koh, Suk-Kyu (Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, 34134 Daejeon, Republic of Korea) ,  Jeong, Jong-Woo (Graduate School of New Drug Discovery and Development, Chungnam National University, 34134 Daejeon, Republic of Korea) ,  Choi, Seo-In (Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, 34134 Daejeon, Republic of Korea) ,  Kim, Rae Man (College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, 50834 Gimhae, Republic of Korea) ,  Koo, Tae-Sung (Graduate School of New Drug Discovery and Development, Chungnam National University, 34134 Daejeon, Republic of Korea) ,  Cho, Kwan Hyung (College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, 50834 Gimhae, Republic of Korea) ,  Seo, Kyoung-Won (Department of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University, 08826 Seoul, Republic of Korea)

Abstract AI-Helper 아이콘AI-Helper

BackgroundFurosemide, a diuretic that acts on the loop of Henle, is commonly used to treat congestive heart failure in veterinary medicine. Some owners have difficulty in administering oral tablet medication to animal patients, which leads to noncompliance, especially during long-term administration...

Keyword

참고문헌 (44)

  1. 1. Hori Y Ohshima N Kanai K Hoshi F Itoh N Higuchi S Differences in the duration of diuretic effects and impact on the renin-angiotensin-aldosterone system of furosemide in healthy dogs J Vet Med Sci 2010 72 1 13 8 10.1292/jvms.09-0259 19893284 

  2. 2. Yancy CW Jessup M Bozkurt B Butler J Casey DE Jr. Colvin MM 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America Circulation 2017 136 6 e137 e61 10.1161/CIR.0000000000000509 28455343 

  3. 3. Biddle TL Yu PN Effect of furosemide on hemodynamics and lung water in acute pulmonary edema secondary to myocardial infarction Am J Cardiol 1979 43 1 86 90 10.1016/0002-9149(79)90049-3 758775 

  4. 4. Davidov M Kakaviatos N Finnerty FA Jr. Intravenous administration of furosemide in heart failure JAMA 1967 200 10 824 9 10.1001/jama.1967.03120230076009 6071618 

  5. 5. Hirai J Miyazaki H Taneike T The Pharmacokinetics and Pharmacodynamics of Furosemide in the Anesthetized Dog J Vet Pharmacol Ther 1992 15 3 231 9 10.1111/j.1365-2885.1992.tb01011.x 1433485 

  6. 6. Lee MG Li T Chiou WL Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of furosemide Biopharm Drug Dispos 1986 7 6 537 47 10.1002/bdd.2510070603 3828484 

  7. 7. Sleeper MM, O’Donnell P, Fitzgerald C, Papich MG. Pharmacokinetics of furosemide after intravenous, oral and transdermal administration to cats. J Feline Med Surg. 2019;21(10):882–6. 

  8. 8. Plumb DC. Furosemide, In: Plumb DC. ed. Veterinary Drug Hand-book. 9th ed. 2018. p. 726 – 31. 

  9. 9. MD. K. Management of heart failure, In: Kittleson MD, Kienle RD. editors. Small Animal Cardiovascular Medicine. St Louis: Mosby. 1998. p.149 – 94. 

  10. 10. Gerald J, Yakatan DDM, Jean Scholler WM, Novick J Jr., Doluisio JT. Absorption, Distribution, Metabolism, and Excretion of Furosemide in Dogs and Monkeys I Analytical Methodology, Metabolism, and Urinary Excretion. J Pharm Sci. 1976;65(No.10): 1456-60. 

  11. 11. Haegeli L Brunner-La Rocca HP Wenk M Pfisterer M Drewe J Krahenbuhl S Sublingual administration of furosemide: new application of an old drug Br J Clin Pharmacol 2007 64 6 804 9 17875188 

  12. 12. Benet LZ Pharmacokinetics/pharmacodynamics of furosemide in man: a review J Pharmacokinet Biopharm 1979 7 1 1 27 10.1007/BF01059438 458552 

  13. 13. El-Sayed MG Atef M El-Gendi AY Youssef SA Disposition kinetics of furosemide in dogs Arch Int Pharmacodyn Ther 1981 253 1 4 10 7325754 

  14. 14. Miyazaki H Hirai J Taneike T The Pharmacokinetics and Pharmacodynamics of Furosemide in Anesthetized Dogs with Normal and Experimentally Decreased Renal-Function Japan J Vet Sci 1990 52 2 265 73 10.1292/jvms1939.52.265 

  15. 15. Francis GS Siegel RM Goldsmith SR Olivari MT Levine TB Cohn JN Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis Ann Intern Med 1985 103 1 1 6 10.7326/0003-4819-103-1-1 2860833 

  16. 16. Hori Y Katou A Tsubaki M Kanai K Nakao R Hoshi F Assessment of diuretic effects and changes in plasma aldosterone concentration following oral administration of a single dose of furosemide or azosemide in healthy dogs Am J Vet Res 2008 69 12 1664 9 10.2460/ajvr.69.12.1664 19046016 

  17. 17. Tsutsui T Tsutamoto T Maeda K Kinoshita M Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failure J Cardiovasc Pharmacol 2001 38 Suppl 1 S81-5 11811366 

  18. 18. Harada K Ukai Y Kanakubo K Yamano S Lee J Kurosawa TA Comparison of the diuretic effect of furosemide by different methods of administration in healthy dogs J Vet Emerg Crit Care (San Antonio) 2015 25 3 364 71 10.1111/vec.12301 25885944 

  19. 19. Chandraratna PA Langevin E O’Dell R Rubenstein C San Pedro S Use of nitroglycerin ointment in congestive heart failure. Results of acute and chronic therapy Cardiology 1978 63 6 337 42 10.1159/000169914 100219 

  20. 20. Zayed R Kamel AO Shukr M El-Shamy AEH An in vitro and in vivo comparative study of directly compressed solid dispersions and freeze dried sildenafil citrate sublingual tablets for management of pulmonary arterial hypertension Acta Pharmaceut 2012 62 3 411 32 10.2478/v10007-012-0027-9 

  21. 21. Tamura G Ichinose M Fukuchi Y Miyamoto T Transdermal Tulobuterol Patch, a Long-Acting beta(2)-Agonist Allergol Int 2012 61 2 219 29 10.2332/allergolint.11-RA-0358 22270072 

  22. 22. Okamura H Arakawa M Miyagawa A Adachi H Incidence of postoperative atrial fibrillation in transdermal beta-blocker patch users is lower than that in oral beta-blocker users after cardiac and/or thoracic aortic surgery Gen Thorac Cardiovasc Surg 2019 67 12 1007 13 10.1007/s11748-019-01131-5 31049816 

  23. 23. Karki S Kim H Na SJ Shin D Jo K Lee J Thin films as an emerging platform for drug delivery Asian J Pharm Sci 2016 11 5 559 74 10.1016/j.ajps.2016.05.004 

  24. 24. De Caro V, Ajovalasit A, Sutera FM, Murgia D, Sabatino MA, Dispenza C. Development and Characterization of an Amorphous Solid Dispersion of Furosemide in the Form of a Sublingual Bioadhesive Film to Enhance Bioavailability. Pharmaceutics. 2017;9(3):22. 

  25. 25. Vondrak B, Barnhart S. Dissolvable films: dissolvable films for flexible product format in drug delivery. 2008. 

  26. 26. Borges AF Silva C Coelho JFJ Simoes S Oral films: Current status and future perspectives I - Galenical development and quality attributes J Control Release 2015 206 1 19 10.1016/j.jconrel.2015.03.006 25747406 

  27. 27. Shoukri RA Ahmed IS Shamma RN In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets Eur J Pharm Biopharm 2009 73 1 162 71 10.1016/j.ejpb.2009.04.005 19406232 

  28. 28. Devarakonda B Otto DP Judefeind AA Hill RA de Villiers MM Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes Int J Pharmaceut 2007 345 1–2 142 53 10.1016/j.ijpharm.2007.05.039 

  29. 29. Branch RA Roberts CJ Homeida M Levine D Determinants of response to frusemide in normal subjects Br J Clin Pharmacol 1977 4 2 121 7 10.1111/j.1365-2125.1977.tb00682.x 861127 

  30. 30. Kaojarern S Day B Brater DC The time course of delivery of furosemide into urine: an independent determinant of overall response Kidney Int 1982 22 1 69 74 10.1038/ki.1982.134 7120755 

  31. 31. van Meyel JJ Smits P Russel FG Gerlag PG Tan Y Gribnau FW Diuretic efficiency of furosemide during continuous administration versus bolus injection in healthy volunteers Clin Pharmacol Ther 1992 51 4 440 4 10.1038/clpt.1992.44 1563213 

  32. 32. Kim EJ Han KS Lee MG Gastrointestinal first-pass effect of furosemide in rats J Pharm Pharmacol 2000 52 11 1337 43 10.1211/0022357001777487 11186241 

  33. 33. Doungngern T Huckleberry Y Bloom JW Erstad B Effect of Albumin on Diuretic Response to Furosemide in Patients with Hypoalbuminemia Am J Crit Care 2012 21 4 280 6 10.4037/ajcc2012999 22751371 

  34. 34. Farless LB Steil N Williams BR Bailey FA Intermittent subcutaneous furosemide: parenteral diuretic rescue for hospice patients with congestive heart failure resistant to oral diuretic Am J Hosp Palliat Care 2013 30 8 791 2 10.1177/1049909112465795 23136114 

  35. 35. Ansel HC, ALJ, Popovich NG. Pharmaceutical Dosage Forms and Drug Delivery Systems. 7th ed. Philadelphia: Lippin-cott Willams & Wilkins; 1999: p. 60–100. 

  36. 36. Ponto LL Schoenwald RD Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II) Clin Pharmacokinet 1990 18 6 460 71 10.2165/00003088-199018060-00003 2191821 

  37. 37. Brater DC Pharmacokinetics of loop diuretics in congestive heart failure Br Heart J 1994 72 2 Suppl S40-3 10.1136/hrt.72.2_Suppl.S40 7946757 

  38. 38. Yakatan GJ Maness DD Scholler J Johnston JT Novick WJ Jr. Doluisio JT Plasma and tissue levels of furosemide in dogs and monkeys following single and multiple oral doses Res Commun Chem Pathol Pharmacol 1979 24 3 465 82 109903 

  39. 39. Pelligand L Guillot E Geneteau A Guyonnet J Magnier R Elliott J Population Pharmacokinetics and Pharmacodynamics Modeling of Torasemide and Furosemide After Oral Repeated Administration in Healthy Dogs Front Vet Sci 2020 7 151 10.3389/fvets.2020.00151 32411731 

  40. 40. Goel Raj Kumar Shazia PS Khanna Sanjay Rakesh Kumar Dixit. Clinical Significance of Half Life of Drugs Int J Pharmacother 2014 4 1 6 7 

  41. 41. Lee Y Kim K Kim M Choi DH Jeong SH Orally disintegrating films focusing on formulation, manufacturing process, and characterization J Pharm Invest 2017 47 3 183 201 10.1007/s40005-017-0311-2 

  42. 42. Kim B-S Park G-T Park M-H Shin YG Cho C-W Preparation and evaluation of oral dissolving film containing local anesthetic agent, lidocaine J Pharm Invest 2017 47 6 575 81 10.1007/s40005-016-0298-0 

  43. 43. USP Convention Inc. R-v, Maryland, USA. United States Pharmacopoeia XXIX2006. p. 1497. 

  44. 44. Kim DH Kim JY Kim AM Maharjan P Ji YG Jang DJ Orlistat-loaded solid SNEDDS for the enhanced solubility, dissolution, and in vivo performance Int J Nanomed 2018 13 7095 106 10.2147/IJN.S181175 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

원문 보기

원문 URL 링크

*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로